Cargando…

Hepatitis C virus (HCV) infection & risk factors for HCV positivity in injecting & non-injecting drug users attending a de-addiction centre in northern India

BACKGROUND & OBJECTIVES: Injecting drug use is a major route of hepatitis C virus (HCV) infection in India, but there may be other risk factors also. This study was carried out to determine the seroprevalence of anti-HCV antibody in injecting drug users (IDUs) vs. non-IDUs (NIDUs), and to study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Basu, Debasish, Sharma, Arun Kumar, Gupta, Sunil, Nebhinani, Naresh, Kumar, Vineet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669866/ https://www.ncbi.nlm.nih.gov/pubmed/26458347 http://dx.doi.org/10.4103/0971-5916.166596

Ejemplares similares

Profile of inhalant users seeking treatment at a de-addiction centre in north India
por: Gupta, Sunil, et al.
Publicado: (2014)

Family burden in injecting versus noninjecting opioid users
por: Nebhinani, Naresh, et al.
Publicado: (2013)

Demographic and clinical profile of substance abusing women seeking treatment at a de-addiction center in north India
por: Nebhinani, Naresh, et al.
Publicado: (2013)

Relationship of reasons and fears of treatment with outcome in substance using population attending a de-addiction centre
por: Sarkar, Siddharth, et al.
Publicado: (2013)

Detection of HCV-Specific IFN-γ Responses in HCV Antibody and HCV RNA Negative Injecting Drug Users
por: Flynn, Jacqueline K, et al.
Publicado: (2014)

Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users
por: Conway, B, et al.
Publicado: (2010)

Molecular Epidemiology of HCV Monoinfection and HIV/HCV Coinfection in Injection Drug Users in Liuzhou, Southern China
por: Tan, Yi, et al.
Publicado: (2008)

HCV Subtype Characterization among Injection Drug Users: Implication for a Crucial Role of Zhenjiang in HCV Transmission in China
por: Zhang, Chiyu, et al.
Publicado: (2011)

HCV monoinfection and HIV/HCV coinfection enhance T-cell immune senescence in injecting drug users early during infection
por: Grady, Bart P. X., et al.
Publicado: (2016)

Diverse HCV Strains And HIV URFS Identified Amongst People Who Inject Drugs In India
por: Rodgers, Mary A., et al.
Publicado: (2020)

Frequency of HBV, HCV and HIV infections among hospitalized injecting drug users in Kashan
por: Sharif, M., et al.
Publicado: (2009)

HCV incidence is associated with injecting partner age and HCV serostatus mixing in young adults who inject drugs in San Francisco
por: Page, Kimberly, et al.
Publicado: (2019)

HIV/HCV co-infection and associated risk factors among injecting drug users in Dar es Salaam, Tanzania: potential for HCV elimination
por: Leyna, Germana Henry, et al.
Publicado: (2019)

Role of HCV Viremia in Corroborated HCV Transmission Events Within Young Adult Injecting Partnerships
por: Hahn, Judith A, et al.
Publicado: (2019)

Initial treatment dropout in patients with substance use disorders attending a tertiary care de-addiction centre in north India
por: Basu, Debasish, et al.
Publicado: (2017)

The Molecular Epidemiological Study of HCV Subtypes among Intravenous Drug Users and Non-Injection Drug Users in China
por: Tao, Jun, et al.
Publicado: (2015)

Cost Effectiveness of Screening Strategies for Early Identification of HIV and HCV Infection in Injection Drug Users
por: Cipriano, Lauren E., et al.
Publicado: (2012)

Epidemic dispersion of HIV and HCV in a population of co-infected Romanian injecting drug users
por: Paraschiv, Simona, et al.
Publicado: (2017)

Control over Drug Acquisition, Preparation, and Injection: Implications for HIV and HCV Risk among Young Female Injection Drug Users
por: Wagner, Karla D., et al.
Publicado: (2013)

Changing pattern of substance abuse in patients attending a de-addiction centre in north India (1978-2008)
por: Basu, Debasish, et al.
Publicado: (2012)

Reaching mEthadone users Attending Community pHarmacies with HCV: an international cluster randomised controlled trial protocol (REACH HCV)
por: Byrne, Christopher, et al.
Publicado: (2020)

The acceptability and feasibility of peer worker support role in community based HCV treatment for injecting drug users
por: Norman, Josephine, et al.
Publicado: (2008)

High HCV seroprevalence and HIV drug use risk behaviors among injection drug users in Pakistan
por: Kuo, Irene, et al.
Publicado: (2006)

Epidemiological aspects of HCV infection in non-injecting drug users in the Brazilian state of Pará, eastern Amazon
por: Oliveira-Filho, Aldemir B, et al.
Publicado: (2014)

Identification of a New HCV Subtype 6xg Among Injection Drug Users in Kachin, Myanmar
por: Ye, Mei, et al.
Publicado: (2019)

Family burden with substance dependence: a study from India
por: Mattoo, Surendra Kumar, et al.
Publicado: (2013)

Metabolic syndrome among substance dependent men: A study from north India
por: Mattoo, Surendra Kumar, et al.
Publicado: (2013)

Prevalences and associated risk factors of HCV/HIV co-infection and HCV mono-infection among injecting drug users in a methadone maintenance treatment program in Taipei, Taiwan
por: Yen, Yung-Feng, et al.
Publicado: (2012)

Comparison of HCV viral load and its genotype distributions in HCV mono- and HIV/HCV co-infected illicit drug users
por: Jamalidoust, Marzieh, et al.
Publicado: (2017)

Comparison of the Efficacies of Direct-Acting Antiviral Treatment for HCV Infection in People Who Inject Drugs and Non-Drug Users
por: Hsu, Jui-Ting, et al.
Publicado: (2022)

Prevalence of HIV and HCV among injecting drug users in three selected WHO-EMRO countries: a meta-analysis
por: Shayan, Shah Jahan, et al.
Publicado: (2021)

State HCV Incidence and Policies Related to HCV Preventive and Treatment Services for Persons Who Inject Drugs — United States, 2015–2016
por: Campbell, Cecily A., et al.
Publicado: (2017)

Injection partnership characteristics and HCV status associations with syringe and equipment sharing among people who inject drugs
por: Mackesy-Amiti, Mary Ellen, et al.
Publicado: (2023)

Injection Drug Use Is a Risk Factor for HCV Infection in Urban Egypt
por: Paez Jimenez, Adela, et al.
Publicado: (2009)

HCV and HIV co-infection among people who inject drugs in Vietnam
por: THINH, Vu Toan, et al.
Publicado: (2020)

Outcomes of Real-World Integrated HCV Microelimination for People Who Inject Drugs: An expansion of the Punjab Model.
por: Dhiman, Radha K., et al.
Publicado: (2021)

Unsterile injection equipment associated with HIV outbreak and an extremely high prevalence of HCV—A case-control investigation from Unnao, India
por: Patil, Sandip, et al.
Publicado: (2020)

Modelling the impact of incarceration and prison‐based hepatitis C virus (HCV) treatment on HCV transmission among people who inject drugs in Scotland
por: Stone, Jack, et al.
Publicado: (2017)

Tramadol Dependence: A Case Series from India
por: Sarkar, Siddharth, et al.
Publicado: (2012)

HCV genotypes distribution pattern in India
por: Bokharaei-Salim, Farah, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_do4hkru06a29b2bv6bf4mfqdfl